Coherus Eyes Further Biosimilar Candidates But Urges Caution

As Company Continues To Advance Multiple Candidates

 
• By Dean Rudge
  
Dollars
Coherus believes it "prudent" to strengthen its balance sheet at this time • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business